Turkish firm Abdi İbrahim acquires major stake in Swiss biotech business OM Pharma
One of Turkey’s largest pharmaceutical companies Abdi İbrahim has set its sights on international expansion after acquiring a 28.5 percent stake of Geneva-based OM Pharma in a deal worth 500 million Swiss francs ($530 million). The deal, announced on 18 Sep., forms part of a larger sale of microbial specialist OM Pharma, after its parent […]